|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2001-5-30
|
|
pubmed:abstractText |
Studies in different animal models and plasma analyses in humans suggest that members of the interleukin-6 (IL-6) cytokine family may be involved in the pathogenesis of congestive heart failure (CHF). Accordingly, we have examined IL-6-related cytokines in chronic CHF in humans by analysing gene and protein expression in myocardium derived from patients with end-stage heart failure and donor hearts.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokine Receptor gp130,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/Growth Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/IL6ST protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/LIF protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Leukemia Inhibitory Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Lymphokines,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Ribonucleases
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0014-2972
|
|
pubmed:author |
pubmed-author:ØieEE,
pubmed-author:AassHH,
pubmed-author:AttramadalHH,
pubmed-author:AukrustPP,
pubmed-author:BjerkeliVV,
pubmed-author:ChristensenGG,
pubmed-author:DamåsJ KJK,
pubmed-author:EikenH GHG,
pubmed-author:FrølandS SSS,
pubmed-author:GeiranO ROR,
pubmed-author:GullestadLL,
pubmed-author:SimonsenSS,
pubmed-author:TønnessenTT,
pubmed-author:YndestadAA
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
389-97
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11380590-Adult,
pubmed-meshheading:11380590-Antigens, CD,
pubmed-meshheading:11380590-Chronic Disease,
pubmed-meshheading:11380590-Cytokine Receptor gp130,
pubmed-meshheading:11380590-Cytokines,
pubmed-meshheading:11380590-Female,
pubmed-meshheading:11380590-Gene Expression Regulation,
pubmed-meshheading:11380590-Growth Inhibitors,
pubmed-meshheading:11380590-Heart Failure,
pubmed-meshheading:11380590-Humans,
pubmed-meshheading:11380590-Immunohistochemistry,
pubmed-meshheading:11380590-Interleukin-6,
pubmed-meshheading:11380590-Leukemia Inhibitory Factor,
pubmed-meshheading:11380590-Lymphokines,
pubmed-meshheading:11380590-Male,
pubmed-meshheading:11380590-Membrane Glycoproteins,
pubmed-meshheading:11380590-Middle Aged,
pubmed-meshheading:11380590-Myocardium,
pubmed-meshheading:11380590-RNA, Messenger,
pubmed-meshheading:11380590-Ribonucleases
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein 130 in end-stage human heart failure.
|
|
pubmed:affiliation |
University of Oslo, The National Hospital, Ullevål Hospital Oslo, Norway. h.g.eiken@klinmed.uio.no
|
|
pubmed:publicationType |
Journal Article
|
